Annual report
9221.TEDINET S100YBWO
Period2025-04-01 → 2026-03-31
Filed2026-06-16
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.0bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥9.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥8.8bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.1bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.7bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.2bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥1.2bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.2bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥838m | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.3bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.5bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥891m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.0bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥263m | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥744m | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥570m | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥891m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥1.0bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥13.9bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥12.2bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥11.3bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥11.3bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥9.3bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.7bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥6.6bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥6.2bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.6bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.0bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥5.1bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥2.1bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.0bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥993m | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.5bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥507m | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.5bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.7bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥817m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.9bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥635m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥444m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥482m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥448m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥350m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.3bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.1bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥380m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥76.87 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥87.88 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.41 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.96 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥63.8 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥535.91 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥483.08 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥427.32 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥430.71 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥236.91 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 44.8% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.4% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.7% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.8% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 15.1% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 19.5% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.2% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 20.8% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 29.6% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 487 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 443 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 452 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 437 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 422 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥8.7bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥7.8bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥7.2bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥6.6bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥6.3bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.1bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥1.1bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.1bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.4bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.1bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥933m | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥719m | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.2bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.4bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥874m | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥1.0bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥197m | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥671m | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥484m | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥13.0bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥11.2bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥10.4bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥10.5bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥8.5bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥7.2bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥6.0bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥5.8bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥5.2bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥4.7bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥4.8bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.9bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥705m | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥674m | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥75.42 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.2 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.81 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.68 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥54.26 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥30 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥28 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥26 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥501.33 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥453.39 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥400.34 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥409.75 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥218.28 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 44.6% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.7% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.2% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.9% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 23.0% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 15.8% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 20.1% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.2% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.9% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 26.9% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 11,779,600 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,779,600 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,760,800 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,880,400 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,480,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 339 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 295 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 276 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 262 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 248 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 64
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2025-04-01 → 2026-03-31 | ¥9m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2026-03-31 | 76 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2026-03-31 | ¥1.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2026-03-31 | ¥1.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥287m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2026-03-31 | ¥35m |
| Reconciling Itemsreconciling | depreciation | 2025-04-01 → 2026-03-31 | ¥90m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥342m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥342m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥8m |
| Biomaterial Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥611m |
| Biomaterial Businessreportable segment | employees | at 2026-03-31 | 227 pure |
| Biomaterial Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥7.3bn |
| Biomaterial Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥7.3bn |
| Biomaterial Businessreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥54m |
| Biomaterial Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥1.1bn |
| Resource Circulation Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥45m |
| Resource Circulation Businessreportable segment | employees | at 2026-03-31 | 75 pure |
| Resource Circulation Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥1.7bn |
| Resource Circulation Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥1.7bn |
| Resource Circulation Businessreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥2m |
| Resource Circulation Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥90m |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥656m |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥9.0bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥9.0bn |
| —segment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥56m |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-04-01 → 2026-03-31 | ¥665m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2026-03-31 | ¥10.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2026-03-31 | ¥10.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥342m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2026-03-31 | ¥1.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2024-04-01 → 2025-03-31 | ¥11m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2025-03-31 | ¥1.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥1.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥290m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2025-03-31 | −¥2m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥76m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥362m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥362m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥8m |
| Biomaterial Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥471m |
| Biomaterial Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥6.8bn |
| Biomaterial Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥6.8bn |
| Biomaterial Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥68m |
| Biomaterial Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Resource Circulation Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥51m |
| Resource Circulation Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.6bn |
| Resource Circulation Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.6bn |
| Resource Circulation Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥4m |
| Resource Circulation Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥72m |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥522m |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥8.4bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥8.4bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥71m |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥533m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥9.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥9.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥362m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2026-03-31 | 6 pure |
| Biomaterial Businessreportable segment | employees | at 2026-03-31 | 193 pure |
| Resource Circulation Businessreportable segment | employees | at 2026-03-31 | 45 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,580
| Item | Context | Value | Unit |
|---|---|---|---|
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E37560-000ResourceCirculationBusinessReportableSegmentMember | 51047000 | JPY |
| Depreciation segment information | Prior1YearDuration_ReportableSegmentsMember | 522313000 | JPY |
| Depreciation segment information | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 10996000 | JPY |
| Depreciation segment information | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 533309000 | JPY |
| Depreciation segment information | Prior1YearDuration_ReconcilingItemsMember | 76403000 | JPY |
| Depreciation segment information | Prior1YearDuration | 609713000 | JPY |
| Revenues from external customers | CurrentYearDuration_jpcrp030000-asr_E37560-000BiomaterialBusinessReportableSegmentMember | 7282273000 | JPY |
| Revenues from external customers | CurrentYearDuration_jpcrp030000-asr_E37560-000ResourceCirculationBusinessReportableSegmentMember | 1698175000 | JPY |
| Revenues from external customers | CurrentYearDuration_ReportableSegmentsMember | 8980449000 | JPY |
| Revenues from external customers | CurrentYearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1027534000 | JPY |
| Revenues from external customers | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 10007983000 | JPY |
| Revenues from external customers | CurrentYearDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYearDuration | 10007983000 | JPY |
| Transactions with other segments | CurrentYearDuration_jpcrp030000-asr_E37560-000BiomaterialBusinessReportableSegmentMember | 54177000 | JPY |
| Transactions with other segments | CurrentYearDuration_jpcrp030000-asr_E37560-000ResourceCirculationBusinessReportableSegmentMember | 1635000 | JPY |
| Transactions with other segments | CurrentYearDuration_ReportableSegmentsMember | 55812000 | JPY |
| Transactions with other segments | CurrentYearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 286594000 | JPY |
| Transactions with other segments | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 342406000 | JPY |
| Transactions with other segments | CurrentYearDuration_ReconcilingItemsMember | -342406000 | JPY |
| Transactions with other segments | CurrentYearDuration | － | JPY |
| Net sales | CurrentYearDuration_jpcrp030000-asr_E37560-000BiomaterialBusinessReportableSegmentMember | 7336450000 | JPY |
| Net sales | CurrentYearDuration_jpcrp030000-asr_E37560-000ResourceCirculationBusinessReportableSegmentMember | 1699811000 | JPY |
| Net sales | CurrentYearDuration_ReportableSegmentsMember | 9036262000 | JPY |
| Net sales | CurrentYearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1314128000 | JPY |
| Net sales | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 10350390000 | JPY |
| Net sales | CurrentYearDuration_ReconcilingItemsMember | -342406000 | JPY |
| Net sales | CurrentYearDuration | 10007983000 | JPY |
| Operating income | CurrentYearDuration_jpcrp030000-asr_E37560-000BiomaterialBusinessReportableSegmentMember | 1057558000 | JPY |
| Operating income | CurrentYearDuration_jpcrp030000-asr_E37560-000ResourceCirculationBusinessReportableSegmentMember | 89871000 | JPY |
| Operating income | CurrentYearDuration_ReportableSegmentsMember | 1147430000 | JPY |
| Operating income | CurrentYearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 35210000 | JPY |
| Operating income | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 1182641000 | JPY |
| Operating income | CurrentYearDuration_ReconcilingItemsMember | -7869000 | JPY |
| Operating income | CurrentYearDuration | 1174771000 | JPY |
| Depreciation segment information | CurrentYearDuration_jpcrp030000-asr_E37560-000BiomaterialBusinessReportableSegmentMember | 610651000 | JPY |
| Depreciation segment information | CurrentYearDuration_jpcrp030000-asr_E37560-000ResourceCirculationBusinessReportableSegmentMember | 45298000 | JPY |
| Depreciation segment information | CurrentYearDuration_ReportableSegmentsMember | 655949000 | JPY |
| Depreciation segment information | CurrentYearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 8587000 | JPY |
| Depreciation segment information | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 664536000 | JPY |
| Depreciation segment information | CurrentYearDuration_ReconcilingItemsMember | 90352000 | JPY |
| Depreciation segment information | CurrentYearDuration | 754889000 | JPY |
| Impairment loss el | Prior1YearDuration_jpcrp030000-asr_E37560-000BiomaterialBusinessReportableSegmentMember | － | JPY |
| Impairment loss el | Prior1YearDuration_jpcrp030000-asr_E37560-000ResourceCirculationBusinessReportableSegmentMember | 46415000 | JPY |
| Impairment loss el | Prior1YearDuration_ReportableSegmentsMember | 46415000 | JPY |
| Impairment loss el | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Impairment loss el | Prior1YearDuration_UnallocatedAmountsAndEliminationMember | － | JPY |
| Impairment loss el | Prior1YearDuration | 46415000 | JPY |
| Cash and deposits | Prior1YearInstant_NonConsolidatedMember | 674488000 | JPY |
| Cash and deposits | CurrentYearInstant_NonConsolidatedMember | 704583000 | JPY |
| Notes receivable trade | Prior1YearInstant_NonConsolidatedMember | 2781000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |